.

Pharmaceutical Business Intelligence

  • Find generic sources and suppliers
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Oxycodone - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for oxycodone?

Oxycodone is the generic ingredient in five branded drugs marketed by Collegium Pharm Inc, Novel Labs Inc, Mayne Pharma Inc, West-ward Pharms Int, Wes Pharma Inc, Mallinckrodt Inc, Vintage Pharms, Alvogen Malta, Ken Lifescience, Lannett Holdings Inc, Roxane, Lehigh Valley, Actavis Elizabeth, Vistapharm, Amneal Pharms, Wockhardt Bio Ag, Sun Pharm Inds Inc, Aurolife Pharma Llc, Epic Pharma Llc, Purdue Pharma Lp, Avanthi Inc, Ani Pharms Inc, Egalet Us Inc, Nesher Pharms, Rhodes Pharms, and Corepharma, and is included in thirty-six NDAs. There are thirty patents protecting this compound. Additional information is available in the individual branded drug profile pages.

This ingredient has thirteen patent family members in five countries.

There are seventeen drug master file entries for oxycodone. One supplier is listed for this compound. There are seven tentative approvals for this compound.

Summary for Generic Name: oxycodone

Tradenames:5
Patents:31
Applicants:26
NDAs:36
Drug Master File Entries: see list17
Suppliers / Packagers: see list1
Bulk Api Vendors: see list14
Clinical Trials: see list134
Patent Applications: see list8,971
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:oxycodone at DailyMed

Pharmacology for Ingredient: oxycodone

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

Tentative approvals for OXYCODONE

Applicant Application No. Form Dosage
► Subscribe► SubscribeTABLET, EXTENDED RELEASE; ORAL10MG
► Subscribe► SubscribeTABLET, EXTENDED RELEASE; ORAL20MG
► Subscribe► SubscribeTABLET, EXTENDED RELEASE; ORAL40MG
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purdue Pharma Lp
OXYCONTIN
oxycodone hydrochloride
TABLET, EXTENDED RELEASE;ORAL022272-004Apr 5, 2010RXYesNo8,309,060► SubscribeY ► Subscribe
Sun Pharm Inds Inc
OXYCODONE HYDROCHLORIDE
oxycodone hydrochloride
TABLET;ORAL090659-004Nov 6, 2012RXNoNo► Subscribe► Subscribe
Purdue Pharma Lp
OXYCONTIN
oxycodone hydrochloride
TABLET, EXTENDED RELEASE;ORAL022272-003Apr 5, 2010RXYesNo7,683,072► SubscribeYY ► Subscribe
Purdue Pharma Lp
OXYCONTIN
oxycodone hydrochloride
TABLET, EXTENDED RELEASE;ORAL022272-004Apr 5, 2010RXYesNo► Subscribe► Subscribe
Egalet Us Inc
OXAYDO
oxycodone hydrochloride
TABLET;ORAL202080-001Jun 17, 2011RXNoNo8,637,540► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: oxycodone

Country Document Number Estimated Expiration
Canada2916869► Subscribe
Japan4694207► Subscribe
Japan2013216707► Subscribe
Japan2009298822► Subscribe
Canada2491572► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: OXYCODONE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
292Luxembourg► SubscribePRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc